NCT06947694
- Conditions
- NSCLC Stage IV Without EGFR/ALK Mutation
- Locations
-
- the second affiliated hospital of Army medical university Chongqing, Chongqing Municipality, China
Clinical trial condition
NSCLC Stage IV Without EGFR/ALK Mutation
Explore clinical trials studying NSCLC Stage IV Without EGFR/ALK Mutation. Study availability and eligibility vary by location and protocol.
4 public trials
2 recruiting studies
NSCLC Stage IV Without EGFR/ALK Mutation trial results
NCT06953843
- Conditions
- NSCLC Stage IV Without EGFR/ALK Mutation
- Locations
-
- the second affiliated hospital of Army medical university Chongqing, Chongqing Municipality, China
Not Yet Recruiting
Tracking T-Cell Responses to Evaluate Pembrolizumab Effectiveness in Advanced Non-Small Cell Lung Cancer
NCT06951399
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Davidoff Comprehensive Cancer Center, Rabin Medical Center Petah Tikva, Israel
Active, Not Recruiting
Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung
NCT03808662
- Conditions
- Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +19 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack Commack, New York, United States